NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

Private health funds are becoming particularly concerned about the burden of long COVID on the health system, five years ...

As South Korea battled a spike in flu cases, misinformation swirled online that the country was suffering a resurgence of the ...

This is the first post in a series about the lingering effects of COVID. The age-honored trope of the transition from an old year to a brand-new one is the handoff from a husk of an aging ...

The following is a summary of “Transitioning to a virtual post-intensive care rehabilitation service in response to the COVID-19 pandemic: results of multidisciplinary focus-groups,” published in the ...

According to the results, 4.5% post-COVID-19 participants met ME/CFS diagnostic criteria, compared to 0.6% participants that had not been infected by SARS-CoV-2 virus. RECOVER is NIH's national ...

Wachter sees some upside in this trend for cities that have large downtown housing bases, like Philadelphia—at least, as they navigate post-COVID reality. City budgets, she says, benefit from ...